Vaughn takes key FDA post
Rockville, Md.-Dr. Steven D. Vaughn has been selected to fill the position of director of Food and Drug Administration Center for Veterinary Medicine's (CVM's) Office of New Animal Drug Evaluation (ONADE).
Rockville, Md.-Dr. Steven D. Vaughn has been selected to fill the position of director of Food and Drug Administration Center for Veterinary Medicine's (CVM's) Office of New Animal Drug Evaluation (ONADE).
Vaughn assumed the new role in November.
Vaughn held positions in both CVM's Office of Surveillance and Compliance(OS&C) and ONADE. He joined CVM in 1987 as a veterinary medical officerin OS&C's Division of Surveillance and in 1991 was promoted to chiefof the antiparasitic and physiological drugs branch in the Division of TherapeuticDrugs for Food Animals in ONADE. In 1992, Vaughn became the director ofONADE's Division of Therapeutic Drugs for Food Animals.
CVM says Vaughn's appointment comes at a time when the Office of NewAnimal Drug Evaluation is facing unprecedented challenges. Rapid advancesin the field of animal biotechnology, the increasingly prominent issue ofantimicrobial resistance, and the potential for user-fee and minor use/minorspecies legislation represent just a few of the many issues facing ONADE.
Vaughn replaces Dr. Andy Beaulieu who was acting office director, ONADE.Beaulieu will resume his position as the associate director for Animal HealthPolicy and Operations.
